SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001479290-17-000014
Filing Date
2017-02-28
Accepted
2017-02-28 17:27:02
Documents
4
Effectiveness Date
2017-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 fy17s-8.htm S-8 100793
2 EXHIBIT 5.1 fy17ex51.htm EX-5.1 8705
3 EXHIBIT 23.1 fy17ex231.htm EX-23.1 2133
4 GRAPHIC cooleya01.jpg GRAPHIC 4382
  Complete submission text file 0001479290-17-000014.txt   118768
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216342 | Film No.: 17649489
SIC: 2834 Pharmaceutical Preparations